Inventor · disambiguated record
Pratik Devasthale
Also filed as: DEVASTHALE PRATIK
34 granted patents·1 pending application·591 citations·filing 2001–2021
97Inventor score
Files withBRISTOL MYERS SQUIBB CO29DEVASTHALE PRATIK2BRISTOL MEYERS SQUIBB CO1BRISTOL MYERS SQUIBB1BRISTOLS MYERS SQUIBB COMPANY1
Top patents by PatentIndex Score
35 records- 0198US6727271B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 27, 2004·92 cites·19 claims
- 0298US6414002B1Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 2, 2002·204 cites·30 claims
- 0397US6653314B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 25, 2003·67 cites·13 claims
- 0496US6673815B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jan 6, 2004·98 cites·35 claims
- 0593US8791091B2Aryl dihydropyridinone and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Jul 29, 2014·18 cites·103 claims
- 0691US9663466B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 30, 2017·8 cites·7 claims
- 0790US9901572B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 27, 2018·6 cites·21 claims
- 0890US9187424B1Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 17, 2015·10 cites·18 claims
- 0989US10695328B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 30, 2020·2 cites·40 claims
- 1088US6919358B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MEYERS SQUIBB CO·Filed 2002·Granted Jul 19, 2005·12 cites·14 claims
- 1187US7521557B2Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methodsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 21, 2009·11 cites·19 claims
- 1286US10369140B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 6, 2019·3 cites·17 claims
- 1386US8580959B2Azolotriazinone melanin concentrating hormone receptor-1 antagonistsDEVASTHALE PRATIK·Filed 2009·Granted Nov 12, 2013·18 cites·19 claims
- 1486US7053106B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 30, 2006·10 cites·26 claims
- 1582US7989433B2Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Aug 2, 2011·4 cites·18 claims
- 1679US10968219B23-substituted propionic acids as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 6, 2021·2 cites·16 claims
- 1779US7279485B2Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 9, 2007·11 cites·11 claims
- 1877US7084162B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 1, 2006·4 cites·3 claims
- 1976US7951793B2Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 31, 2011·2 cites·6 claims
- 2075US8415386B2Azolopyrrolone melanin concentrating hormone receptor-1 antagonistsDEVASTHALE PRATIK·Filed 2009·Granted Apr 9, 2013·3 cites·20 claims
- 2175US2021161869A1Aryl dihydropyridinones and piperidinone mgat2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2272US10966967B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 6, 2021·0 cites·20 claims
- 2369US7557143B2Thyroid receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 7, 2009·4 cites·9 claims
- 2464US7241780B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOLS MYERS SQUIBB COMPANY·Filed 2004·Granted Jul 10, 2007·2 cites·38 claims
- 2561US11884661B23-substituted propionic acids as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jan 30, 2024·0 cites·11 claims
- 2659US11639353B2Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted May 2, 2023·0 cites·14 claims
- 2757US8263659B2Thyroid receptor ligandsRYONO DENIS E·Filed 2009·Granted Sep 11, 2012·0 cites·11 claims
- 2856US12275720B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB·Filed 2021·Granted Apr 15, 2025·0 cites·13 claims
- 2953US12286424B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Apr 29, 2025·0 cites·19 claims
- 3053US12269819B2Small molecule inhibitors of Galectin-3BRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 8, 2025·0 cites·13 claims
- 3152US11014922B2Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 25, 2021·0 cites·12 claims
- 3250US8754211B2Azolotriazinone melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 17, 2014·0 cites·13 claims
- 3344US7579479B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 25, 2009·0 cites·9 claims
- 3441US10851098B2Azole amides and amines as alpha v integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 1, 2020·0 cites·16 claims
- 3530US9974778B2Substituted pyridinones as MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 22, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Pratik Devasthale files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →